Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Melinta Therapeutics
Pharma
Mundipharma, CorMedix score trial victory for antifungal Rezzayo
Mundipharma and CorMedix have scored in a phase 3 trial of Rezzayo in preventing fungal diseases in patients receiving stem cell transplants.
Kevin Dunleavy
Apr 27, 2026 3:52pm
CorMedix buys Melinta for $300M, adding 7 marketed products
Aug 7, 2025 11:36am
FDA says yes to Allecra's antibiotic combo after CRL for another
Feb 27, 2024 11:44am
Venatorx, Melinta's antibiotic rejected over manufacturing issues
Feb 23, 2024 10:55am
FDA signs off on Cidara's antifungal Rezzayo for candidiasis
Mar 23, 2023 11:07am
Melinta won FDA approval for skin infection fighter Kimyrsa
Mar 15, 2021 12:35pm
